Facing up to the global challenges of ageing

  title={Facing up to the global challenges of ageing},
  author={Linda Partridge and Joris Deelen and Pieternella E Slagboom},
Longer human lives have led to a global burden of late-life disease. However, some older people experience little ill health, a trait that should be extended to the general population. Interventions into lifestyle, including increased exercise and reduction in food intake and obesity, can help to maintain healthspan. Altered gut microbiota, removal of senescent cells, blood factors obtained from young individuals and drugs can all improve late-life health in animals. Application to humans will… 

Health and Pro-Longevity Interventions

This chapter discusses whether the conventionally used drugs can be repurposed to target the aging process per se and the advances and challenges in this emerging research field are summarized.

Identifying Potential Ageing-Modulating Drugs In Silico

Longevity leap: mind the healthspan gap

Life expectancy has increased by three decades since the mid-twentieth century. Parallel healthspan expansion has however not followed, largely impeded by the pandemic of chronic diseases afflicting

The genetics of human ageing

Bringing together different strands of genetic research, including results from recent large-scale genome-wide association studies relevant to human ageing, the authors highlight how genetics can further the authors' understanding of the underlying mechanisms of ageing.

Revisiting the Hallmarks of Aging to Identify Markers of Biological Age

This narrative review gathered information about biomarkers of aging under the perspective of Geroscience, and proposed a putative biomarker of healthy aging, chosen for their association with mortality, age-related chronic diseases, frailty and/or functional loss.

Identification of 12 genetic loci associated with human healthspan

A genome-wide association study and genetic risk model for human healthspan, the length of morbidity-free life, and strong genetic correlations between healthspan and all-cause mortality, life-history, and lifestyle traits are found.

Genetics of frailty: a longevity perspective.

Genetics of extreme human longevity to guide drug discovery for healthy ageing

In this Perspective, recent insights into the genetics of extreme human longevity are summarized and the use of this rare phenotype to identify genetic variants as molecular targets for gaining insight into the physiology of healthy ageing and the development of new therapies to extend the human healthspan is proposed.

The landscape of aging

In an attempt to bring full-fledged understanding to both the aging process and age-associated diseases, this work reviews the descriptive, conceptual, and interventive aspects of the landscape of aging composed of a number of layers at the cellular, tissue, organ, organ system, and organismal levels.

Nutritional concerns later in life

Evidence is presented for the importance of healthful dietary patterns and points towards specific nutritional concerns later in life and current food-based dietary guidelines propagate a shift into the direction of Mediterranean type of diets including more plant-based foods.



Lifespan and Healthspan: Past, Present, and Promise.

While moving to life expectancies above age 95 and compressing morbidity substantially may require significant scientific breakthroughs; significant improvement in health and increases in life expectancy in the United States could be achieved with behavioral, life style, and policy changes that reduce socioeconomic disparities and allow us to reach the levels of health and life expectancy achieved in peer societies.

Interventions to Slow Aging in Humans: Are We Ready?

There was consensus that there is sufficient evidence that aging interventions will delay and prevent disease onset for many chronic conditions of adult and old age and their potential to be safe and effective in extending human healthspan.

Health and function of participants in the Long Life Family Study: A comparison with other cohorts

Several priority phenotypes are suggested for inclusion in future genetic analysis to identify loci contributing to exceptional survival in individuals recruited for the Long Life Family Study.

Extending Healthy Life Span—From Yeast to Humans

Dietary restriction and reduced activity of nutrient-sensing pathways may slow aging by similar mechanisms, which have been conserved during evolution, and their potential application to prevention of age-related disease and promotion of healthy aging in humans, and the challenge of possible negative side effects.

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

It is shown that 3 months of rapamycin treatment is sufficient to increase life expectancy by up to 60% and improve measures of healthspan in middle-aged mice and this transient treatment is also associated with a remodeling of the microbiome, including dramatically increased prevalence of segmented filamentous bacteria in the small intestine.